Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alefacept does not effectively treat severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.